Medicare Enrolled

Dr. Cheryl Lindley, FNP

Nurse Practitioner - Family · Burlington, NC
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
3128 COMMERCE PL, Burlington, NC 27215
3362704894
In practice since 2013 (13 years)
NPI: 1518308188 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Lindley from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lindley? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Lindley

Dr. Cheryl Lindley is a nurse practitioner - family in Burlington, NC, with 13 years of NPI registration. Based on federal Medicare data, Dr. Lindley performed 829 Medicare services across 510 unique beneficiaries.

Between the years covered by Open Payments, Dr. Lindley received a total of $14,970 from 68 pharmaceutical and/or device companies across 842 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in nurse practitioner - family. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Lindley is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 13 years in practice ▲ Top 17% volume in NC $14,970 industry payments

Medicare Practice Summary

Medicare Utilization ↗
829
Medicare services
Top 17% in NC for nurse practitioner - family
510
Unique beneficiaries
$54
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~64 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
145 $49 $105
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
99 $69 $156
Ultrasound of arm and leg arteries
A non-invasive imaging test that uses sound waves to examine the blood vessels in the arms and legs. It evaluates blood flow and checks for blockages or other vascular issues.
96 $66 $196
Urinalysis, manual
A manual laboratory examination of a urine sample to check for various substances and cells.
84 $3 $15
Autonomic nervous system testing with tilt
This test evaluates the function of the sympathetic and parasympathetic nervous systems. It involves monitoring the patient for at least five minutes while they are tilted.
49 $93 $218
Autonomic nervous system function test
This test evaluates how well the sympathetic nervous system is functioning. It assesses the automatic control of bodily processes such as heart rate and blood pressure.
48 $78 $187
Drug test with direct observation
A drug screening test performed under direct observation to ensure the sample is provided correctly. This method is used to verify the integrity of the specimen collection process.
38 $12 $25
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
33 $8 $30
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
33 $104 $209
Echocardiogram, transthoracic
An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function.
31 $103 $298
Annual intensive behavioral therapy for cardiovascular disease, 15 minutes
A yearly, in-person session focused on intensive behavioral therapy to help manage cardiovascular disease. The session lasts for 15 minutes and is conducted with the patient individually.
31 $21 $40
Annual alcohol misuse screening, 5 to 15 minutes 30 $15 $27
Annual depression screening 30 $15 $25
Ultrasound of head and neck blood flow, bilateral
An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck.
29 $117 $293
Annual wellness visit, follow-up
A follow-up annual wellness visit that includes a personalized prevention plan of service.
29 $104 $169
Electrocardiogram (EKG), 12-lead
A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report.
12 $7 $25
Advance care planning consultation, first 30 min
A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion.
12 $49 $123
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
3.7% high complexity
19.1% medium
77.2% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$14,970
Total received (2021-2024)
Avg $3,742/year across 4 years
Top 1% in NC for nurse practitioner - family
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
68
Companies
842
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$14,958 (99.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$12 (0.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,891
2023
$4,389
2022
$3,972
2021
$3,717

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$460
Lilly USA, LLC
$267
Novo Nordisk Inc
$257
Teva Pharmaceuticals USA, Inc.
$249
PFIZER INC.
$179
Exact Sciences Corporation
$174
Novartis Pharmaceuticals Corporation
$167
Bayer Healthcare Pharmaceuticals Inc.
$161
AstraZeneca Pharmaceuticals LP
$157
Esperion Therapeutics, Inc.
$80
Otsuka America Pharmaceutical, Inc.
$70
AIMMUNE THERAPEUTICS, INC.
$65
GlaxoSmithKline, LLC.
$61
Boehringer Ingelheim Pharmaceuticals, Inc.
$49
Alkermes, Inc.
$47
Sumitomo Pharma America, Inc.
$45
Corcept Therapeutics
$44
Axsome Therapeutics, Inc.
$42
Astellas Pharma US Inc
$41
Mylan Specialty L.P.
$40
Janssen Pharmaceuticals, Inc
$40
Amgen Inc.
$30
Actelion Pharmaceuticals US, Inc.
$28
Grifols USA, LLC
$25
Radius Health, Inc.
$24
IRONWOOD PHARMACEUTICALS, INC
$21
Phathom Pharmaceuticals, Inc.
$19
Merck Sharp & Dohme LLC
$17
Vanda Pharmaceuticals Inc.
$17
SHIELD THERAPEUTICS INC
$16
Top 3 companies account for 34.0% of 2024 payments
All-time payments by company (2021-2024) ›
ABBVIE INC.
$1,436
AstraZeneca Pharmaceuticals LP
$1,137
Teva Pharmaceuticals USA, Inc.
$1,132
Novo Nordisk Inc
$925
Esperion Therapeutics, Inc.
$748
Lilly USA, LLC
$740
GlaxoSmithKline, LLC.
$729
Boehringer Ingelheim Pharmaceuticals, Inc.
$576
Alkermes, Inc.
$532
AbbVie Inc.
$463
Otsuka America Pharmaceutical, Inc.
$459
Novartis Pharmaceuticals Corporation
$354
PFIZER INC.
$348
Exact Sciences Corporation
$345
Bayer Healthcare Pharmaceuticals Inc.
$339
Sunovion Pharmaceuticals Inc.
$329
Grifols USA, LLC
$289
Amgen Inc.
$273
Merck Sharp & Dohme LLC
$249
E.R. Squibb & Sons, L.L.C.
$239
Amarin Pharma Inc.
$217
IMPEL PHARMACEUTICALS INC.
$198
Biohaven Pharmaceutical Holding Company Ltd.
$186
UPSHER-SMITH LABORATORIES LLC
$175
Mylan Specialty L.P.
$169
Sumitomo Pharma America, Inc.
$165
Corium, LLC
$157
Axsome Therapeutics, Inc.
$137
Radius Health, Inc.
$125
SANOFI-AVENTIS U.S. LLC
$124
Biohaven Pharmaceuticals, Inc.
$108
Nestle HealthCare Nutrition Inc.
$103
IDORSIA PHARMACEUTICALS US INC
$103
Ironwood Pharmaceuticals, Inc
$92
Janssen Pharmaceuticals, Inc
$92
Bayer HealthCare Pharmaceuticals Inc.
$91
Neurocrine Biosciences, Inc.
$79
AIMMUNE THERAPEUTICS, INC.
$65
RedHill Biopharma Inc.
$65
Xeris Pharmaceuticals, Inc.
$63
Shield Therapeutics Inc
$60
Avion Pharmaceuticals
$54
NESTLE HEALTHCARE NUTRITION INC.
$46
ITI, Inc.
$45
Corcept Therapeutics
$44
Astellas Pharma US Inc
$41
Takeda Pharmaceuticals U.S.A., Inc.
$37
Lundbeck LLC
$34
Merck Sharp & Dohme Corporation
$34
Collegium Pharmaceutical, Inc.
$31
Galderma Laboratories, L.P.
$29
Actelion Pharmaceuticals US, Inc.
$28
VIVUS LLC
$28
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$26
Kowa Pharmaceuticals America, Inc.
$26
Abbott Laboratories
$26
Aytu BioPharma, Inc.
$26
Allergan, Inc.
$26
EISAI INC.
$25
IRONWOOD PHARMACEUTICALS, INC
$21
ARBOR PHARMACEUTICALS, INC.
$19
Phathom Pharmaceuticals, Inc.
$19
Vanda Pharmaceuticals Inc.
$17
SHIELD THERAPEUTICS INC
$16
Currax Pharmaceuticals LLC
$15
Supernus Pharmaceuticals, Inc.
$15
Eisai Inc.
$14
Azurity Pharmaceuticals, Inc.
$13
Top 3 companies account for 24.7% of all-time payments
Associated products mentioned in payments ›
ABILIFY MAINTENA · ACCRUFER · AIRSUPRA · AJOVY · ANORO ELLIPTA · ARISTADA · AUSTEDO · Adlarity · Aimovig · Austedo XR · Auvelity · BELSOMRA · BOTOX · BREZTRI · Balcoltra · Belbuca · CAMZYOS · CAPLYTA · CREON · Cologuard Collection Kit · Dayvigo · ELIQUIS · EMGALITY · ENTRESTO · Edarbi · Edarbyclor · FARXIGA · FASENRA · FreeStyle Lite system · GEMTESA · GVOKE HYPOPEN · GVOKE PFS · HETLIOZ · INGREZZA · JARDIANCE · Karbinal · Kerendia · Korlym · LATUDA · LEQVIO · LINZESS · LO LOESTRIN FE · LONHALA MAGNAIR · LYBALVI · Linzess · Livalo · MOUNJARO · NEXLETOL · NEXLIZET · NURTEC ODT · ONZETRA XSAIL · OPSUMIT · Otezla · Ozempic · PAXLOVID · PREMARIN · PREVNAR 20 · Prolastin-C Liquid · QSYMIA · QULIPTA · QUVIVIQ · Qsymia · REXULTI · RYBELSUS · Rybelsus · SOLIQUA 100/33 · SPIRIVA · SPRAVATO · STEGLATRO · STIOLTO RESPIMAT · SYMBICORT · SYNJARDY · Saxenda · TOSYMRA · TRADJENTA · TRELEGY ELLIPTA · TRINTELLIX · TROKENDI XR · TRULICITY · Talicia · Trudhesa · Tymlos · UBRELVY · UZEDY · VERQUVO · VIBERZI · VOQUEZNA · VRAYLAR · Vascepa · Veozah · Wegovy · XARELTO · XIFAXAN · XTAMPZA · YUPELRI · Yupelri · ZENPEP · ZEPBOUND
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 1% for nurse practitioner - family in NC.

Looking for a nurse practitioner - family in Burlington?
Compare family nurse practitioners in the Burlington area by procedure volume, costs, and industry payment transparency.
Browse family nurse practitioners nearby

Geographic Context

Family nurse practitioners within 10 mi
333
Per 100K population
191.1
County median income
$64,445
Nearest hospital
MOSES H. CONE MEMORIAL HOSPITAL, THE
14.6 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Lindley is a clinical cardiology specialist, with above-average Medicare volume (top 17% in NC), with low-engagement industry engagement in the top 1% of NC peers.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Lindley experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Lindley performed 145 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Lindley receive payments from pharmaceutical companies?
Yes. Dr. Lindley received a total of $14,970 from 68 companies across 842 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lindley's costs compare to other family nurse practitioners in Burlington?
Dr. Lindley's average Medicare payment per service is $54. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lindley) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →